
Swetha Kambhampati
@SwethaKMD
Followers
476
Following
841
Media
16
Statuses
285
Assistant Professor at City of Hope; Alum: UCSF heme/onc, Hopkins IM, Stanford Med; Interested in lymphoma and CART
Los Angeles, CA
Joined February 2010
I got my ARB losses back. @dom_dillionz @praween_nusrat @IsmayaRania @KeerthiGeeth @seriouscawcaw @SadracChora @mazharkazmi123 @Blessroth.
0
0
0
Im SHIB for always @nunez_julian @hex_xyiv @karshaleos @Crofwgkta @rost_1989 @diazruben16sj @MUSICSAOLOR @vinccirom.
0
0
0
SHIB for life @KazeemKhaled @186 @ZakaCrypto @devanpr03 @JosephDShook @Div_R2022 @an49787142 @SuyatnoJayadin2 @unyil0109.
0
0
0
Chilling with my ARB reimbursement money @Irmatralala_ @Abdulaz84267922 @michael27677957 @MindySpurlock1 @T1_034 @Nino369Nino369 @HoaTrongTuyt1 @Moneymagnet84.
0
0
0
Im SHIB for always @Nidhi90868859 @allwar71 @Emerald09918692 @LLove6688 @mimi_VOD @AxSidh @pjmlantunes @TheFreedomProt1.
0
0
0
I just went into beta its so FIRE @GLC_Inc_ @SamuelP40277471 @ConnieG168 @ClemonTinnel @Hutchin95272841 @SosoMauro @kisaan5556678 @0xmengzi.
0
0
0
When's public ARB @maron_MaHaLo @EvanANorman @Homelander144 @ThnhNgu02050662 @dung_nhan_vao @nachampn @elekxmiki @minisatthu @kinobe_ @Kriptoagatmi.
0
0
0
RT @cityofhope: Developing the treatments of tomorrow is hard work. @DoctorAKrishnan, M.D., and @elizabeth_budde, M.D., Ph.D., are leading….
0
2
0
RT @Blood_Cancers: Axicabtagene ciloleucel showed a significant improvement in OS over standard of care in patients with relapsed or refrac….
0
1
0
RT @Blood_Cancers: 🔊OUT NOW: This all-new episode of The HemOnc Pulse features host @chadinabhan speaking with @SwethaKMD of @cityofhope an….
0
4
0
I got my Shib Yards @OlegDCH @Iura57163635 @CherkutP @HuongNt40173119 @Dim4err_ @413647746Peter @mohammedhafida1 @NdkhoaE.
0
0
0
RT @Lymphoma_Doc: Huge news! ZUMA-7 trial shows axi-cel improves overall survival in patients with second-line aggressive lymphoma, compare….
0
8
0
RT @GCC_Cortes: Dr. Ayushi Chauhan @Chauhan_AF from @GACancerCenter named the 2023 Stephanie A. Gregory Distinguished Scholar by the Lympho….
0
3
0
RT @Blood_Cancers: 🔊Coming Thursday, 3/23: An all-new episode of The HemOnc Pulse features host @chadinabhan speaking with @SwethaKMD of @c….
0
5
0
RT @ColtonLadbury: Excited the City of Hope experience with bridging therapy prior to CAR T for LBCL is published. Thanks for the collabora….
0
4
0
Phenomenal and inspirational week at LRF LSRMP! great mentorship and developed life long friendships and connections! Grateful for the experience @lymphoma @cityofhope.
Amazing week with LRF LSRMP at Lake Las Vegas. Great protocol development. Meeting mentors and colleagues was invaluable! @lymphoma @OSUHematology
0
1
14
RT @DanilovLab: Great group at the LRF Sci Res Mentoring Program in Las Vegas @DrCarlaCasulo @SwethaKMD
0
1
0
RT @VJHemOnc: #Tandem23 | @SwethaKMD of @cityofhope discusses real-world outcomes of patients with transformed R/R DLBCL treated with CAR-T….
0
3
0
RT @Blood_Cancers: Pola-R-CHP can be more cost-effective than R-CHOP in patients with treatment-naïve DLBCL in certain circumstances, accor….
bloodcancerstoday.com
Polatuzumab in combination with chemotherapy may be cost-effective for some cancers.
0
1
0